CoChat

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomized prospective controlled trial.

Open access
Hochreiter, Marcel, Köhler, Thomas, Schweiger, Anna Maria, Keck, Fritz Sixtus, Bein, Berthold, von Spiegel, Tilman, Schroeder, Stefan · 2009 · Critical Care

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Introduction: The development of resistance by bacterial species is a compelling issue to reconsider indications and administration of antibiotic treatment. Adequate indications and duration of therapy are particularly important for the use of highly potent substances in the intensive care setting. Until recently, no laboratory marker has been available to differentiate bacterial infection from viral or non-infectious inflammatory reaction; however, over the past years, procalcitonin (PCT) is the first among a large array of inflammatory variables that offers this possibility. The present study aimed to investigate the clinical usefulness of PCT for guiding antibiotic therapy in surgical intensive care patients. Methods: All patients requiring antibiotic therapy based on confirmed or highly suspected bacterial infections and at least two concomitant systemic inflammatory response syndrome criteria were eligible. Patients were randomly assigned to either a PCT-guided (study group) or a standard (control group) antibiotic regimen. Antibiotic therapy in the PCT-guided group was discontinued, if clinical signs and symptoms of infection improved and PCT decreased to <1 ng/ml or the PCT value was >1 ng/ml, but had dropped to 25 to 35% of the initial value over three days. In the control group antibiotic treatment was applied as standard regimen over eight days. Results: A total of 110 surgical intensive care patients receiving antibiotic therapy after confirmed or high-grade suspected infections were enrolled in this study. In 57 patients antibiotic therapy was guided by daily PCT and clinical assessment and adjusted accordingly. The control group comprised 53 patients with a standardized duration of antibiotic therapy over eight days. Demographic and clinical data were comparable in both groups. However, in the PCT group the duration of antibiotic therapy was significantly shorter than compared to controls (5.9 +/- 1.7 versus 7.9 +/- 0.5 days, P < 0.001) without negative effects on clinical outcome. Conclusions: Monitoring of PCT is a helpful tool for guiding antibiotic treatment in surgical intensive care patients. This may contribute to an optimized antibiotic regimen with beneficial effects on microbial resistance and costs in intensive care medicine. Annotation: Results were previously published in German in Anaesthesist 2008; 57: 571–577 (PMID: 18463831). Trial registration: ISRCTN10288268

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/cc7903

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Sequential Organ Failure Assessment scores. No difference in score was seen between patients with procalcitonin-guided antibiotic treatment (filled columns) and the control group (empty columns). Mean ± standard deviation. SOFA = Sequential Organ Failure Assessment.
Figure 1 Sequential Organ Failure Assessment scores. No difference in score was seen between patients with procalcitonin-guided antibiotic treatment (filled columns) and the control group (empty columns). Mean ± standard deviation. SOFA = Sequential Organ Failure Assessment.CC BY · PubMed Central
Figure 2 Leukocyte values. No difference in values was seen between patients with procalcitonin-guided antibiotic treatment (filled columns) and the control group (empty columns). Mean ± standard deviation.
Figure 2 Leukocyte values. No difference in values was seen between patients with procalcitonin-guided antibiotic treatment (filled columns) and the control group (empty columns). Mean ± standard deviation.CC BY · PubMed Central
Figure 3 IL-6 concentrations. No difference in concentration was seen between patients with procalcitonin-guided antibiotic treatment (filled columns) and the control group (empty columns). Mean ± standard deviation.
Figure 3 IL-6 concentrations. No difference in concentration was seen between patients with procalcitonin-guided antibiotic treatment (filled columns) and the control group (empty columns). Mean ± standard deviation.CC BY · PubMed Central
Figure 4 C-reactive protein concentrations. No difference in concentration was seen between patients with procalcitonin-guided antibiotic treatment (filled columns) and the control group (empty columns). Mean ± standard deviation. CRP = C-reactive protein.
Figure 4 C-reactive protein concentrations. No difference in concentration was seen between patients with procalcitonin-guided antibiotic treatment (filled columns) and the control group (empty columns). Mean ± standard deviation. CRP = C-reactive protein.CC BY · PubMed Central
Figure 5 Procalcitonin concentrations. No difference in concentration was seen between patients with procalcitonin (PCT)-guided antibiotic treatment (filled columns) and the control group (empty columns). Mean ± standard deviation.
Figure 5 Procalcitonin concentrations. No difference in concentration was seen between patients with procalcitonin (PCT)-guided antibiotic treatment (filled columns) and the control group (empty columns). Mean ± standard deviation.CC BY · PubMed Central
Figure 6 Procalcitonin levels solely shown for the intervention arm. In the group with procalcitonin (PCT)-guided antibiotic therapy duration, the PCT values starting on the fourth day are significantly lower in comparison to the initial value (box-plots with lower quartile, median and upper quartile, 0.1- and 0.9-quantile for the whisker length and outliers as item representation). • = Outliers, *P < 0.05.
Figure 6 Procalcitonin levels solely shown for the intervention arm. In the group with procalcitonin (PCT)-guided antibiotic therapy duration, the PCT values starting on the fourth day are significantly lower in comparison to the initial value (box-plots with lower quartile, median and upper quartile, 0.1- and 0.9-quantile for the whisker length and outliers as item representation). • = Outliers, *P < 0.05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 315

Metadata

Authors
Hochreiter, M., Köhler, T., Schweiger, A. M., Keck, F. S., Bein, B., von Spiegel, T., & Schroeder, S.
Affiliations
  • Westküstenkliniken Brunsbüttel und Heide gGmbH (DE)
  • University Hospital Schleswig-Holstein (DE)
Venue
Critical Care
Published
2009-06-03
Volume
13
Issue
3
Pages
R83-R83
ISSN
1364-8535 (ISSN-L)
OpenAlex
W2109928541
Cited by
315
References
29
Citations by year
2026: 7 · 2025: 12 · 2024: 10 · 2023: 13 · 2022: 10 · 2021: 22 · 2020: 9 · 2019: 16 · 2018: 21 · 2017: 32 · 2016: 18 · 2015: 23 · 2014: 18 · 2013: 28 · 2012: 32
FWCI
17.09
Type
journal article
Language
en
Open access
Licence
Locations
  • Critical Care (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Keywords
procalcitonin, antibiotic duration, antibiotic stewardship, surgical intensive care patients, bacterial infection, systemic inflammatory response syndrome, antibiotic de-escalation, antimicrobial resistance, inflammatory markers
MeSH terms
Aged, Anti-Bacterial Agents, Calcitonin, Diagnosis, Differential, Female, Humans, Male, Postoperative Complications, Prospective Studies, Protein Precursors, Biomarkers, Calcitonin Gene-Related Peptide, Drug Monitoring, Systemic Inflammatory Response Syndrome, Sepsis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomized prospective controlled trial. https://app.cochat.ai/papers/10.1186/cc7903
The paper
Hochreiter, M., Köhler, T., Schweiger, A. M., Keck, F. S., Bein, B., von Spiegel, T., & Schroeder, S. (2009). Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomized prospective controlled trial. Critical Care. https://doi.org/10.1186/cc7903

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.